Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (30)
Mengfan Zhang, Zongmei Wu, Sandra Serna Salas, Magnolia Martinez Aguilar, Maria C. Trillos‐Almanza, Manon Buist‐Homan & Han Moshage. (2023) Arginase 1 expression is increased during hepatic stellate cell activation and facilitates collagen synthesis. Journal of Cellular Biochemistry.
Crossref
Crossref
Michael Bitzer, Sabrina Groß, Jörg Albert, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, Achim KautzDavid Krug, Christian La Fougère, Hauke Lang, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta RiemerUlrike Ritterbusch, Elke Roeb, Jörn RüsselBarbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina TholenJörg Trojan, Ingo van ThielArndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle & Nisar Malek. (2023) S3-Leitlinie Diagnostik und Therapie biliärer Karzinome. Zeitschrift für Gastroenterologie 61:04, pages 420-440.
Crossref
Crossref
Michael Bitzer, Sabrina Groß, Jörg Albert, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, Achim KautzDavid Krug, Christian La Fougère, Hauke Lang, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta RiemerUlrike Ritterbusch, Elke Roeb, Jörn RüsselBarbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina TholenJörg Trojan, Ingo van ThielArndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle & Nisar Malek. (2023) S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion. Zeitschrift für Gastroenterologie 61:04, pages e92-e156.
Crossref
Crossref
Olivier Govaere & Quentin M. Anstee. 2023. Encyclopedia of Cell Biology. Encyclopedia of Cell Biology
610
621
.
Francesca Terracciani, Andrea Falcomatà, Paolo Gallo, Antonio Picardi & Umberto Vespasiani-Gentilucci. (2022) Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers. Journal of Physiology and Biochemistry.
Crossref
Crossref
Nong Li, Huiwen Tan, Aixia Xie, Cheng Li, Xuan Fu, Weiting Xang, Amina Kirim & Xuefang Huang. (2022) Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes. BMC Endocrine Disorders 22:1.
Crossref
Crossref
Elyisha Hanniman, Andreu F. Costa, Chris V. Bowen, Mohamed Abdolell, Ashley Stueck, Magnus McLeod, Kevork Peltekian, James Rioux & Sharon E. Clarke. (2022)
Prospective Evaluation of Virtual
MR
Elastography With Diffusion‐Weighted Imaging in Subjects With
Nonalcoholic
Fatty Liver Disease
. Journal of Magnetic Resonance Imaging 56:5, pages 1448-1456.
Crossref
Crossref
Mohamed El-Kassas, Joaquín Cabezas, Paula Iruzubieta Coz, Ming-Hua Zheng, Juan Pablo Arab & Abeer Awad. (2022) Nonalcoholic Fatty Liver Disease: Current Global Burden. Seminars in Liver Disease 42:03, pages 401-412.
Crossref
Crossref
Tatia Khachidze, Gocha Barbakadze, Gela Sulaberidze & Koba Burnadze. (2022) The role of gut microflora dysbiosis in clinical manifestation of patients with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.. International Journal of Scientific Research and Management 10:07, pages 658-667.
Crossref
Crossref
Sabrina Voesch, M. Bitzer & N. Malek. (2022) Klinische Bedeutung der neuen S3-Leitlinie zum hepatozellulären und biliären Karzinom für die PraxisClinical relevance of the new S3 guideline on hepatocellular carcinoma and biliary tract cancer for practitioners. Der Radiologe 62:3, pages 200-204.
Crossref
Crossref
Marina V. Maevskaya, Yulia V. Kotovskaya, Vladimir T. Ivashkin, Olga N. Tkacheva, Ekaterina A. Troshina, Marina V. Shestakova, Valeriy V. Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Ekaterina N. Dudinskaya, Ekaterina V. Ershova, Khava B. Kodzoeva, Ksenia A. Komshilova, Natalia V. Korochanskaya, Alexander Yu. Mayorov, Ekaterina E. Mishina, Maria Yu. Nadinskaya, Igor G. Nikitin, Nana V. Pogosova, Aida I. Tarzimanova & Minara Sh. Shamkhalova. (2022) The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities. Terapevticheskii arkhiv 94:2, pages 216-253.
Crossref
Crossref
Voesch Sabrina, Bitzer Michael, Albert Jörg, Bartenstein Peter, Bechstein Wolf, Blödt Susanne, Brunner Thomas, Dombrowski Frank, Evert Matthias, Follmann Markus, La Fougère Christian, Freudenberger Paul, Geier Andreas, Gkika Eleni, Götz Martin, Hammes Elke, Helmberger Thomas, Hoffmann Ralf-Thorsten, Hofmann Wolf-Peter, Huppert Peter, Kautz Achim, Knötgen Gabi, Körber Jürgen, Krug David, Lammert Frank, Lang Hauke, Langer Thomas, Lenz Philipp, Mahnken Andreas, Meining Alexander, Micke Oliver, Nadalin Silvio, Nguyen Huu Phuc, Ockenga Johann, Oldhafer Karl-Jürgen, Paprottka Philipp, Paradies Kerstin, Pereira Philippe, Persigehl Thorsten, Plauth Mathias, Plentz Ruben, Pohl Jürgen, Riemer Jutta, Reimer Peter, Ringwald Johanna, Ritterbusch Ulrike, Roeb Elke, Schellhaas Barbara, Schirmacher Peter, Schmid Irene, Schuler Andreas, von Schweinitz Dietrich, Seehofer Daniel, Sinn Marianne, Stein Alexander, Stengel Andreas, Steubesand Nadine, Stoll Christian, Tannapfel Andrea, Taubert Anne, Trojan Jörg, van Thiel Ingo, Tholen Reina, Vogel Arndt, Vogl Thomas, Vorwerk Hilke, Wacker Frank, Waidmann Oliver, Wedemeyer Heiner, Wege Henning, Wildner Dane, Wittekind Christian, Wörns Marcus-Alexander, Galle Peter & Malek Nisar. (2022) S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms. Zeitschrift für Gastroenterologie 60:01, pages e56-e130.
Crossref
Crossref
Danial Efendy Goon, Sharaniza Ab-Rahim, Amir Hakimi Mohd Sakri, Musalmah Mazlan, Jen Kit Tan, Mardiana Abdul Aziz, Norizal Mohd Noor, Effendi Ibrahim & Siti Hamimah Sheikh Abdul Kadir. (2021) Untargeted serum metabolites profiling in high-fat diet mice supplemented with enhanced palm tocotrienol-rich fraction using UHPLC-MS. Scientific Reports 11:1.
Crossref
Crossref
Francisca dos Santos Coelho, Marta Borges‐Canha, Madalena Hafe, João Sérgio Neves, Catarina Vale, Ana Rita Leite, Davide Carvalho & Adelino Leite‐Moreira. (2020) Effects of sodium‐glucose co‐transporter 2 inhibitors on liver parameters and steatosis: A meta‐analysis of randomized clinical trials. Diabetes/Metabolism Research and Reviews 37:6.
Crossref
Crossref
Jiwon Kim, Minyoung Lee, Soo Yeon Kim, Ji-Hye Kim, Ji Sun Nam, Sung Wan Chun, Se Eun Park, Kwang Joon Kim, Yong-ho Lee, Joo Young Nam & Eun Seok Kang. (2021) Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts. Endocrinology and Metabolism 36:4, pages 823-834.
Crossref
Crossref
Sahar Rafiee, Hamed Mohammadi, Abed Ghavami, Erfan Sadeghi, Zahra Safari & Gholamreza Askari. (2021) Efficacy of resveratrol supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials. Complementary Therapies in Clinical Practice 42, pages 101281.
Crossref
Crossref
Mohammad H. Jamal & Rawan El-Abd. 2021. Laparoscopic Sleeve Gastrectomy. Laparoscopic Sleeve Gastrectomy
115
137
.
Cosimo Colletta, Alessandro Colletta & Giuseppe Placentino. (2020) Lifestyle and silymarin: a fight against liver damage in NAFLD associated - prediabetic disease. Journal of Diabetes & Metabolic Disorders 19:2, pages 883-894.
Crossref
Crossref
Yoshio Sumida, Toshihide Shima, Yasuhide Mitsumoto, Takafumi Katayama, Atsushi Umemura, Kanji Yamaguchi, Yoshito Itoh, Masashi Yoneda & Takeshi Okanoue. (2020) Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan. International Journal of Molecular Sciences 21:12, pages 4337.
Crossref
Crossref
Yala K. Reddy, Hemnishil K. Marella, Yu Jiang, Surosree Ganguli, Peter Snell, Pradeep S.B. Podila, Benedict Maliakkal & Sanjaya K. Satapathy. (2020) Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies. Journal of Clinical and Experimental Hepatology 10:3, pages 245-254.
Crossref
Crossref
Helen Jarvis, Dawn Craig, Robert Barker, Gemma Spiers, Daniel Stow, Quentin M. Anstee & Barbara Hanratty. (2020) Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies. PLOS Medicine 17:4, pages e1003100.
Crossref
Crossref
Chia-Hsien Chang & Motonobu Sakaguchi. (2019) Incidence and causes of mildly to moderately elevated aminotransferase in Japanese patients with type 2 diabetes. Diabetology International 11:1, pages 57-66.
Crossref
Crossref
Andrea A. Florio, Barry I. Graubard, Baiyu Yang, Jake E. Thistle, Marie C. Bradley, Katherine A. McGlynn & Jessica L. Petrick. (2019) Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink. European Journal of Epidemiology 34:9, pages 871-878.
Crossref
Crossref
Qun Liu, Shousheng Liu, Lizhen Chen, Zhenzhen Zhao, Shuixian Du, Quanjiang Dong, Yongning Xin & Shiying Xuan. (2019) Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review). Experimental and Therapeutic Medicine.
Crossref
Crossref
Olubunmi O Olubamwo, Jyrki K Virtanen, Jussi Pihlajamäki & Tomi-Pekka Tuomainen. (2019) Association of fatty liver disease with mortality outcomes in an Eastern Finland male cohort. BMJ Open Gastroenterology 6:1, pages e000219.
Crossref
Crossref
Amedeo Lonardo, Simonetta Lugari, Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli & Mauro Maurantonio. (2018) A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?. Acta Diabetologica 56:4, pages 385-396.
Crossref
Crossref
Mattia Bellan, Cosimo Colletta, Matteo Nazzareno BarbagliaLivia SalmiRoberto ClericiVenkata Ramana MallelaLuigi Mario CastelloGiuseppe SagliettiGian Piero Carnevale SchiancaRosalba MinisiniMario Pirisi. (2019) Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms. Diabetes & Metabolism Journal 43:5, pages 700.
Crossref
Crossref
Sang Bae Lee, Min Kyung Kim, Shinae KangKahui ParkJung Hye KimSu Jung BaikJi Sun NamChul Woo AhnJong Suk Park. (2019) Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults. Endocrinology and Metabolism 34:2, pages 179.
Crossref
Crossref
O. M. Drapkina, R. N. Shepel, E. P. Yakovenko & E. V. Zyatenkova. (2019) Non-invasive methods for detection of progressive fibrosis in patients with nonalcoholic fat liver disease. Profilakticheskaya meditsina 22:2, pages 82.
Crossref
Crossref
Marta Seghieri, Alexander S. Christensen, Andreas Andersen, Anna Solini, Filip K. Knop & Tina Vilsbøll. (2018) Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD. Frontiers in Endocrinology 9.
Crossref
Crossref